$1.2 Billion to Disrupt Cancer

23/06/2017  |  Inside The PMCF |  Posted by: Paul Alofs

New research indicates nearly 50% of Canadians will be diagnosed with cancer in their lifetime.  This is a frightening statistic about a terrible disease. 

Paul Alofs at J2CCCancer is a highly disruptive disease which evolves, mutates, hides, and recurs without warning and often with little predictability. The people researching and treating cancer need to be as disruptive in their thinking as this disease is. Disruption has occurred in many sectors and in all geographies. Disruption is urgently required as we confront cancer.  

I joined The Princess Margaret Cancer Foundation in 2003 and under my watch the PMCF has raised $1.2 billion in net fundraising. The PMCF has been productively disruptive in our fundraising techniques, but we also fund productively disruptive researchers like Dr. Tak Mak and clinician-scientists like Dr. Jon Irish.  

New technologies in genomics, robotics, and artificial intelligence (A.I.) are already transforming and disrupting past practices for targeting and treating cancer. Sean Parker, of Facebook and Napster fame, has been a public advocate of disruptive thinking in areas like immunotherapy, for which he has written massive and generous cheques to support transformational research. Indeed, the "hacking culture" and rapid innovation of Silicon Valley is urgently needed as we confront cancer.  

True disruption rarely occurs from the existing leaders or organizations which are viewed as leaders. True disruption usually comes from outside the sector or organization. Think of Tesla, Amazon, Airbnb and dozens of others.  

When you support the passion capital of The PMCF to Conquer Cancer In Our Lifetime, you are supporting the disruptive thinking found in one of the world’s top 5 cancer research centres.  

The Princess Margaret is on the front line and it embraces transformational thinking and disruptive medicine and technologies to improve patient outcomes for cancer patients across Canada and around the world.  

Here’s to the disruptors and the transformational leaders who lead the way in genomics, robotics, A.I. and the important new world of disrupting cancer.